Neurocrine Bioscience buy Stifel Nicolaus
Start price
31.07.25
/
50%
€115.25
Target price
31.07.26
€152.22
Performance (%)
-3.73%
Price
12.03.26
€110.95
Summary
This prediction is currently active. With a performance of -3.73%, the BUY prediction for Neurocrine Bioscience by Stifel_Nicolaus is down slightly. This prediction currently runs until 31.07.26. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -1.771% | -1.771% |
| iShares Core DAX® | -1.338% | -5.619% |
| iShares Nasdaq 100 | -1.067% | 2.598% |
| iShares Nikkei 225® | -1.991% | -6.512% |
| iShares S&P 500 | -1.316% | 0.905% |
Comments by Stifel_Nicolaus for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Stifel Nicolaus from $166.00 to $174.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.35
11.12.25
11.12.25
€160.83
11.12.26
11.12.26
-15.53%
12.03.26
12.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€157.11
29.10.26
29.10.26
-5.85%
12.03.26
12.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€109.85
18.12.23
18.12.23
€131.90
18.12.24
18.12.24
16.61%
19.12.24
19.12.24